Generic Prescription Drug Settlements: Here’s Who’s Eligible for Cash
October 1, 2026 Attorneys general settlements resolve litigation that alleged major prescription drug makers agreed to fix prices for over 100 generics sold nationwide.
Lawsuit Filings
$5.55M Metformin Settlements Partially Resolve Class Action Litigation Over Contaminated Diabetes Meds
May 21, 2026 Two class action settlements partially resolve multidistrict litigation over generic metformin-containing drugs contaminated with NDMA.
![Avet's Metformin Diabetes Drug Found to Contain Probable Carcinogen, Class Action Claims [UPDATE]](/media/thumb/newswire-thumb-bw_360x360.png)
Avet's Metformin Diabetes Drug Found to Contain Probable Carcinogen, Class Action Claims [UPDATE]
April 3, 2020 According to a class action, generic metformin manufactured by Heritage Pharmaceuticals has been found to contain dangerously high levels of a probable carcinogen.
Thirteen New Cases Added to Generic Drug Price Fixing MDL
September 6, 2017 Thirteen new cases have been filed in Pennsylvania federal court as part of a multidistrict litigation accusing numerous pharmaceutical companies of conspiring to fix the prices of generic drugs.
Seven More Lawsuits Stacked on to Generic Drug Price-Fixing MDL
June 6, 2017 Seven more lawsuits have been filed this week as part of a multidistrict litigation that accuses the pharmaceutical companies of conspiring to fix generic drug prices.
Lawsuit: Drug Manufacturers Accused of Price-Fixing Conspiracy
April 5, 2017 Aurobindo Pharma USA, Inc., Citron Pharma LLC, Teva Pharmaceuticals USA, Inc., Heritage Pharmaceuticals, Inc. and two Heritage executives are the defendants in a lawsuit.